Verition Fund Management’s Bicycle Therapeutics BCYC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-280,327
| Closed | -$3.92M | – | 2647 |
|
|
2024
Q4 | $3.92M | Buy |
280,327
+68,176
| +32% | +$954K | 0.02% | 830 |
|
|
2024
Q3 | $4.8M | Sell |
212,151
-54,598
| -20% | -$1.24M | 0.02% | 656 |
|
|
2024
Q2 | $5.4M | Sell |
266,749
-74,117
| -22% | -$1.5M | 0.03% | 516 |
|
|
2024
Q1 | $8.49M | Sell |
340,866
-399,673
| -54% | -$9.95M | 0.06% | 328 |
|
|
2023
Q4 | $13.4M | Sell |
740,539
-175,843
| -19% | -$3.18M | 0.1% | 158 |
|
|
2023
Q3 | $18.4M | Buy |
916,382
+237,370
| +35% | +$4.77M | 0.21% | 89 |
|
|
2023
Q2 | $17.3M | Buy |
679,012
+96,454
| +17% | +$2.46M | 0.23% | 85 |
|
|
2023
Q1 | $12.4M | Buy |
582,558
+201,709
| +53% | +$4.29M | 0.17% | 134 |
|
|
2022
Q4 | $11.3M | Buy |
380,849
+32,336
| +9% | +$957K | 0.18% | 106 |
|
|
2022
Q3 | $8.11M | Sell |
348,513
-50,510
| -13% | -$1.17M | 0.09% | 230 |
|
|
2022
Q2 | $6.7M | Buy |
399,023
+264,819
| +197% | +$4.44M | 0.13% | 175 |
|
|
2022
Q1 | $5.89M | Sell |
134,204
-30,511
| -19% | -$1.34M | 0.07% | 225 |
|
|
2021
Q4 | $10M | Sell |
164,715
-14,546
| -8% | -$885K | 0.07% | 115 |
|
|
2021
Q3 | $7.46M | Sell |
179,261
-32,613
| -15% | -$1.36M | 0.06% | 133 |
|
|
2021
Q2 | $6.43M | Sell |
211,874
-28,260
| -12% | -$858K | 0.06% | 139 |
|
|
2021
Q1 | $7.17M | Buy |
240,134
+206,300
| +610% | +$6.16M | 0.08% | 103 |
|
|
2020
Q4 | $607K | Buy |
33,834
+2,803
| +9% | +$50.3K | 0.01% | 514 |
|
|
2020
Q3 | $591K | Buy |
+31,031
| New | +$591K | 0.01% | 444 |
|